Olivier Burgy (Dijon, France), Sabine Bartel (Borstel, Germany), Martin Witzenrath (Berlin, Germany), Adam Giangreco (London, United Kingdom)
A role for the accessory type III transforming growth factor β receptor (Tgfbr3) in lung alveolarisation
Agnieszka Pozarska (Giessen, Germany), Agnieszka Pozarska, Gero Niess, Werner Seeger, Rory Morty
|  |
Refinement of the hyperoxia-based experimental mouse model of bronchopulmonary dysplasia
Claudio Nardiello (Bad Nauheim, Germany), Claudio Nardiello, Ivana Mizíková, Jordi Ruiz-Camp, Werner Seeger, Rory Morty
| |
Optimising the delivery of antagomiRs to the neonatal mouse lung
Jonas Hönig (Bad Nauheim, Germany), Jonas Hönig, Ivana Mizíková, Claudio Nardiello, Werner Seeger, Rory Morty
| |
Assessing the impact of parenteral caffeine administration on experimental bronchopulmonary dysplasia
Philipp Rath (Bad Nauheim, Germany), Philipp Rath, Claudio Nardiello, David Surate, Werner Seeger, Rory Morty
| |
Generation of an immortalized functional alveolar epithelial cell line originating from human induced pluripotent stem cells
Amiq Gazdhar (Bern, Switzerland), Luca Tamo, Youssef Hibaoui, Sampada Kallol, Marco Alves, Christiane Albrecht, Anis Feki, Amiq Gazdhar, Thomas Geiser
| |
LSC Abstract – Activation of FGF9 and 18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts
Audrey Joannes (Paris, France), Audrey Joannes, Madeleine Jaillet, Arnaud Mailleux, Bruno Crestani
| |
Therapeutic efficacy of a novel LPA1 receptor antagonist, UD-009, in a bleomycin-induced pulmonary fibrosis model
Kenji Nishikawa (Yamaguchi, Japan), Kenji Nishikawa, Eiji Okanari, Yuuko Shinohara, Hironobu Matsunaga, Hiroshi Nishida, Noriaki Iwase, Shigeru Ushiyama
| |
Fibroblast growth factor 9 (FGF9) modulates mesothelial cells plasticity to decrease differentiation and migration in vitro
Audrey Joannes (Paris, France), Audrey Joannes, Aurélien Justet, Philippe Bonniaud, Jean Michel Sallenave, Bruno Crestani, Arnaud Mailleux
| |
MiRNA-200b inhibits epithelial-mesenchymal transition in TGF-β1 induced human bronchial epithelial cells
Shameem Sultanali Ladak (Newcastle upon Tyne, United Kingdom), Shameem Sultanali Ladak, Chris Ward, Simi Ali
|  |
Inhibition of collagen cross-links by novel LOXL2 selective inhibitors in an in-vitro model of fibroblastic foci of IPF
James Roberts (Southampton, United Kingdom), James Roberts, Kerry Lunn, Victoria Tear, Mark Jones, Donna Davies, Lucy Cao, Wolfgang Jarolimek, Phillip Monk
| |
The effects of tobramycin on pulmonary fibroblast function
Suzanne Edgar (Portsmouth, United Kingdom), Suzanne Edgar, David Laight, Janis Shute
| |
Human airway trypsin-like protease: Friend or foe in idiopathic pulmonary fibrosis?
Awen Menou (Paris, France), Awen Menou, Sophie Moog, Bruno Crestani, Keren Borenstajn
| |
Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis
Kenji Nemoto (Ibaraki, Japan), Kenji Nemoto, Shuji Oh-ishi, Manato Taguchi, Shunichi Nishima, Norihito Hida, Kazufumi Yoshida, Kai Yazaki, Kentaro Hyodo, Jun Kanazawa, Miura Yukiko, Takio Takaku, Kenji Hayashihara, Takefumi Saito
| |
Evaluation of romidepsin (FK228) as a potential therapy for idiopathic pulmonary fibrosis (IPF)
Franco Conforti (Southamtpon, United Kingdom), Franco Conforti, Elizabeth Davies, Mark Jones, Claire Calderwood, Aiman Alzetani, Paul Skipp, Jane Warner, Philip Molyneaux, David Smart, Teresa Tetley, Tom Havelock, Toby Maher, Thomas Thatcher, Summet Mahajan, Benjamin Marshall, Luca Richeldi, Patricia Sime, Katherine O’Reilly, Donna Davies
| |
Prostacyclin and VEGF in the rejection process after lung transplantation – A possible biomarker
Annika Andersson Sjoland (Lund, Sweden), Annika Andersson Sjoland, Anna-Karin Larsson Callerfelt, Lena Thiman, Oskar Hallgren, Ingrid Skog, Lennart Hansson, Leif Eriksson, Leif Bjermer, Gunilla Westergren-Thorsson
| |
Specialized-proresolving mediators and trancriptomic signatures in bleomycin-induced lung fibrosis
Marc Dubourdeau (Toulouse, France), Marc Dubourdeau, Gerald Chene, Vincent Baillif, Charlotte Guigne, Estelle Wanecq, Emeline Van Goethem
| |
LATE-BREAKING ABSTRACT: Morphology and molecular basis of damage stem cell niche respiratory acini (SCNRA) in idiopathic interstitial pneumonia (IIP)
Evgenia Kogan (Moscow, Russian Federation), Evgenia Kogan, Sophia Demura, Vecheslav Paukov
| |
LATE-BREAKING ABSTRACT: Interfacial sensing a new regulator of pulmonary epithelial barrier function
Daria Korejwo (Innsbruck, Austria), Daria Korejwo, Georg F. Vogel, Veronika E. Winkelmann, Paul Dietl, Manfred Frick, Kai E. Gottschalk, Thomas Haller, Nina Hobi
| |
LATE-BREAKING ABSTRACT: KCa3.1 ion channel-blockade reduces pulmonary fibrotic responses via the inhibition of fibroblast proliferation
Louise Organ (Northcote, Australia), Louise Organ, Emmanuel Koumoundouros, Barbara Bacci, Wayne Kimpton, Chrishan Samuel, Glen Westall, Ian Glaspole, Ken Snibson, Jade Jaffar
| |
LSC Abstract - Differentiation between inflammation and hyperinflammation in the murine lung
Kathleen Reiss (Aachen, Germany), Kathleen Reiss, Marco Schlepütz, Christian Martin, Stefan Uhlig
| |